IL113022A - Antibody conjugates with improved properties - Google Patents

Antibody conjugates with improved properties

Info

Publication number
IL113022A
IL113022A IL11302295A IL11302295A IL113022A IL 113022 A IL113022 A IL 113022A IL 11302295 A IL11302295 A IL 11302295A IL 11302295 A IL11302295 A IL 11302295A IL 113022 A IL113022 A IL 113022A
Authority
IL
Israel
Prior art keywords
improved properties
antibody conjugates
conjugates
antibody
properties
Prior art date
Application number
IL11302295A
Other versions
IL113022A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL113022A0 publication Critical patent/IL113022A0/en
Publication of IL113022A publication Critical patent/IL113022A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL11302295A 1994-03-21 1995-03-17 Antibody conjugates with improved properties IL113022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94810173 1994-03-21

Publications (2)

Publication Number Publication Date
IL113022A0 IL113022A0 (en) 1995-06-29
IL113022A true IL113022A (en) 2000-02-29

Family

ID=8218230

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11302295A IL113022A (en) 1994-03-21 1995-03-17 Antibody conjugates with improved properties

Country Status (11)

Country Link
JP (1) JPH0820545A (en)
KR (1) KR950031111A (en)
AU (1) AU1481795A (en)
CA (1) CA2144936A1 (en)
FI (1) FI951276A (en)
HU (1) HUT71776A (en)
IL (1) IL113022A (en)
NO (1) NO951061L (en)
NZ (1) NZ270734A (en)
RU (1) RU95104325A (en)
ZA (1) ZA952269B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865737B1 (en) * 2004-02-03 2006-03-31 Anteis Sa BIOCOMPATIBLE RETICLE GEL

Also Published As

Publication number Publication date
AU1481795A (en) 1995-09-28
NO951061D0 (en) 1995-03-20
CA2144936A1 (en) 1995-09-22
HU9500586D0 (en) 1995-04-28
ZA952269B (en) 1995-09-21
NZ270734A (en) 1997-05-26
KR950031111A (en) 1995-12-18
FI951276A0 (en) 1995-03-17
IL113022A0 (en) 1995-06-29
FI951276A (en) 1995-09-22
JPH0820545A (en) 1996-01-23
NO951061L (en) 1995-09-22
HUT71776A (en) 1996-01-29
RU95104325A (en) 1996-12-27

Similar Documents

Publication Publication Date Title
GB9422383D0 (en) Antibodies
TJ328B (en) Interferron conjugates
PL330111A1 (en) Concentyratyed antibody preparation
EP1073464A4 (en) Monoclonal antibodies with reduced immunogenicity
GB9603256D0 (en) Antibodies
GB9809839D0 (en) Antibody
EP0765166A4 (en) Radiolabeled annexin-galactose conjugates
IL116456A0 (en) Oligonucleotide-dendrimer conjugates
GB9828700D0 (en) Antibody
IL113022A0 (en) Antibody conjugates with improved properties
IL98777A0 (en) Antibody conjugates
GB9419256D0 (en) Antibody and conjugates
ZA9510827B (en) Oligonucleotide-dendrimer conjugates
HU9501990D0 (en) Rapamycin conjugates and antibodies
GB9021210D0 (en) Antigen-antibody conjugates
ZA954678B (en) Monoclonal antibody against cd44v6
IL134049A0 (en) Anti-cryptdin antibodies
GB9406243D0 (en) Antibodies
GB9406222D0 (en) Huminised antibodies
GB9415331D0 (en) Antibodies
GB9406244D0 (en) Altered antibodies
GB9401597D0 (en) Altered antibodies
GB9400761D0 (en) Carbohydrate conjugates
GB9404300D0 (en) Antibodies with improved effector function
GB9110444D0 (en) Antigen-antibody conjugates ii

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees